Targeting DAX-1 in embryonic stem cells and cancer

Expert Opinion on Therapeutic Targets

Volumn 14, Issue 2, 2010, Pages 169-177

  Lalli, Enzo ^a,b   Alonso, Javier ^a,c  

^a CNRS   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cancer; Nuclear receptors; Stem cells; Transcription factors

Indexed keywords

NUCLEAR RECEPTOR DAX 1; TRANSCRIPTION FACTOR;

ADRENAL CORTEX; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL FUNCTION; ADRENAL MEDULLA; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; EMBRYONIC STEM CELL; EWING SARCOMA; GENE INACTIVATION; GENE MUTATION; GENITAL SYSTEM; HORMONE SYNTHESIS; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; ORGANOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; RNA INTERFERENCE; TRANSCRIPTION INITIATION; UPREGULATION;

ADRENAL CORTEX; ANIMALS; CELL DIFFERENTIATION; DAX-1 ORPHAN NUCLEAR RECEPTOR; EMBRYONIC STEM CELLS; HUMANS; NEOPLASMS; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEIN C-FLI-1; REPRODUCTION;

EID: 74949113273     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728220903531454     Document Type: Review

References (82)

1. Bardoni B, Zanaria E, Guioli S, et al. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 1994;7:497-501
2. Adrenal hypoplasia, congenital;AHC. Online Mendelian Inheritance in Man, Baltimore, MD: Johns Hopkins University, 1986: Available from: http://www.ncbi.nlm.nih.gov/entrez/ dispomim.cgi?id=300200 [Last accessed 7 December 2009]
3. Zanaria E, Muscatelli F, Bardoni B, et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994;372:635-641.
4. Muscatelli F, Strom TM, Walker AP, et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994;372:672-676
5. Habiby RL, Boepple P, Nachtigall L, et al. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism. Evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest 1996;98:1055-1062
6. Wiltshire E, Couper J, Rodda C, et al. Variable presentation of X-linked adrenal hypoplasia congenita. J Pediatr Endocrinol Metab 2001;14:1093-1096
7. Lin L, Gu WX, Ozisik G, et al. Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience. J Clin Endocrinol Metab 2006;91:3048-3054
8. Lalli E, Bardoni B, Zazopoulos E, et al. A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol Endocrinol 1997;11:1950-1960
9. Lalli E, Sassone-Corsi P. DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol Endocrinol 2003;17:1445-1453
10. Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 1999;97:161-163
11. Ito M, Yu R, Jameson JL. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 1997;17:1476-1483
12. Lehmann SG, Lalli E, Sassone-Corsi P. X-linked adrenal hypoplasia congenita is caused by abnormal nuclear localization of the DAX-1 protein. Proc Natl Acad Sci USA 2002;99:8225-8230
13. Lehmann SG, Wurtz JM, Renaud JP, et al. Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patients. Hum Mol Genet 2003;12:1063-1072
14. Ikeda Y, Swain A, Weber TJ, et al. Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol Endocrinol 1996;10:1261-1272
15. Val P, Lefrançois-Martinez AM, Veyssière G, et al. SF-1 a key player in the development and differentiation of steroidogenic tissues. Nucl Recept 2003;1:8
16. Zazopoulos E, Lalli E, Stocco DM, et al. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 1997;390:311-315.
17. Verrijn Stuart AA, Ozisik G, de Vroede MA, et al. An amino-terminal DAX1 (NR0B1) missense mutation associated with isolated mineralocorticoid deficiency. J Clin Endocrinol Metab 2007;92:755-761
18. Ferraz-de-Souza B, Martin F, Mallet D, et al. CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease. J Clin Endocrinol Metab 2009;94:678-683
19. Xu B, Yang WH, Gerin I, et al. Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis. Mol Cell Biol 2009;29:1719-1734
20. Babu PS, Bavers DL, Beuschlein F, et al. Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. Endocrinology 2002;143:665-673
21. Kawabe K, Shikayama T, Tsuboi H, et al. Dax-1 as one of the target genes of Ad4BP/ SF-1. Mol Endocrinol 1999;13:1267-1284
22. Lalli E, Melner MH, Stocco DM, et al. DAX-1 blocks steroid production at multiple levels. Endocrinology 1988;139:4237-4243
23. Zhang H, Thomsen JS, Johansson L, et al. DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem 2000;275:39855-39859
24. Suzuki T, Kasahara M, Yoshioka H, et al. LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1. Mol Cell Biol 2003;23:238-249
25. Sablin EP, Woods A, Krylova IN, et al. The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1. Proc Natl Acad Sci USA 2008;105:18390-18395
26. Goodfellow PN, Camerino G. DAX-1, an 'antitestis' gene. Cell Mol Life Sci 1999;55:857-863
27. Swain A, Narvaez V, Burgoyne P, et al. Dax1 antagonizes Sry action in mammalian sex determination. Nature 1998;391:761-767
28. Merke DP, Tajima T, Baron J, et al. Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. N Engl J Med 1999;340:1248-1252
29. Yu RN, Ito M, Saunders TL, et al. Role of Ahch in gonadal development and gametogenesis. Nat Genet 1998;20:353-357
30. Meeks JJ, Crawford SE, Russell TA, et al. Dax1 regulates testis cord organization during gonadal differentiation. Development 2003;130:1029-1036
31. Meeks JJ, Weiss J, Jameson JL. Dax1 is required for testis determination. Nat Genet 2003;34:32-33
32. Bouma GJ, Albrecht KH, Washburn LL, et al. Gonadal sex reversal in mutant Dax1 XY mice: a failure to upregulate Sox9 in pre-Sertoli cells. Development 2005;132:3045-3054
33. Park SY, Lee EJ, Emge D, et al. A phenotypic spectrum of sexual development in Dax1 (Nr0b1)-deficient mice: consequence of the C57BL/6J strain on sex determination. Biol Reprod 2008;79:1038-1045
34. Seminara SB, Achermann JC, Genel M, et al. X-linked adrenal hypoplasia congenita: a mutation in DAX1 expands the phenotypic spectrum in males and females. J Clin Endocrinol Metab 1999;84:4501-4509
35. Mantovani G, Ozisik G, Achermann JC, et al. Hypogonadotropic hypogonadism as a presenting feature of late-onset X-linked adrenal hypoplasia congenita. J Clin Endocrinol Metab 2002;87:44-48
36. Mitsui K, Tokuzawa Y, Itoh H, et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003;113:631-642
37. Niakan KK, Davis EC, Clipsham RC, et al. Novel role for the orphan nuclear receptor Dax1 in embryogenesis, different from steroidogenesis. Mol Genet Metab 2006;88:261-271.
38. Loh YH, Wu Q, Chew JL, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006;38:431-440
39. Wang J, Rao S, Chu J, et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006;444:364-368
40. Kim J, Chu J, Shen X, et al. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008;132:1049-1061
41. Sun C, Nakatake Y, Ura H, et al. Stem cell-specific expression of Dax1 is conferred by STAT3 and Oct3/4 in embryonic stem cells. Biochem Biophys Res Commun 2008;372:91-96
42. Sun C, Nakatake Y, Akagi T, et al. Dax1 binds to Oct3/4 and inhibits its transcriptional activity in embryonic stem cells. Mol Cell Biol 2009;29:4574-4583
43. Khalfallah O, Rouleau M, Barbry P, et al. Dax-1 knockdown in mouse embryonic stem cells induces loss of pluripotency and multilineage differentiation. Stem Cells 2009;27:1529-1537
44. Xie CQ, Jeong Y, Fu M, et al. Expression profiling of nuclear receptors in human and mouse embryonic stem cells. Mol Endocrinol 2009;23:724-733
45. Battista MC, Otis M, Côté M, et al. Extracellular matrix and hormones modulate DAX-1 localization in the human fetal adrenal gland. J Clin Endocrinol Metab 2005;90:5426-5431
46. Lehmann SG, Sassone-Corsi P, Lalli E. Heat shock affects trafficking of DAX-1 by inducing its rapid and reversible cytoplasmic localization. Endocrine 2005;28:137-144
47. Zubair M, Parker KL, Morohashi K. Developmental links between the fetal and adult zones of the adrenal cortex revealed by lineage tracing. Mol Cell Biol 2008;28:7030-7040
48. Schulte DM, Shapiro I, Reincke M, et al. Expression and spatio-temporal distribution of differentiation and proliferation markers during mouse adrenal development. Gene Expr Patterns 2007;7:72-81
49. Gummow BM, Scheys JO, Cancelli VR, et al. Reciprocal regulation of a glucocorticoid receptor-steroidogenic factor-1 transcription complex on the Dax-1 promoter by glucocorticoids and adrenocorticotropic hormone in the adrenal cortex. Mol Endocrinol 2006;20:2711-2723
50. Reincke M, Beuschlein F, Lalli E, et al. DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis. J Clin Endocrinol Metab 1998;83:2597-2600
51. Lefrançois-Martinez AM, Bertherat J, Val P, et al. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumours. J Clin Endocrinol Metab 2004;89:3010-3019
52. Shibata H, Ikeda Y, Mukai T, et al. Expression profiles of COUP-TF, DAX-1, and SF-1 in the human adrenal gland and adrenocortical tumours: possible implications in steroidogenesis. Mol Genet Metab 2001;74:206-216
53. Doghman M, Karpova T, Rodrigues GA, et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 2007;21:2968-2987
54. Doghman M, Lalli E. A matter of dosage: SF-1 in adrenocortical development and cancer. Ann Endocrinol 2009;70:148-152
55. Abd-Elaziz M, Akahira J, Moriya T, et al. Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome. Cancer Sci 2003;94:980-985
56. Conde I, Alfaro JM, Fraile B, et al. DAX-1 expression in human breast cancer comparison with estrogen receptors ER-alpha, ER-beta and androgen receptor status. Breast Cancer Res 2004;6:R140-8
57. Saito S, Ito K, Suzuki T, et al. Orphan nuclear receptor DAX-1 in human endometrium and its disorders. Cancer Sci 2005;96:645-652
58. Nakamura Y, Suzuki T, Arai Y, et al. Nuclear receptor DAX1 in human prostate cancer: a novel independent biological modulator. Endocrine J 2009;56:39-44
59. Helguero LA, Hedengran Faulds M, Förster C, et al. DAX-1 expression is regulated during mammary epithelial cell differentiation. Endocrinology 2006;147:3249-3259
60. Seo DC, Sung JM, Cho HJ, et al. Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer 2007;6:75. Published online 22 November 2007, doi: 10.1186/1476-4598-6-75 (Pubitemid 351248078)
61. Hadnagy A, Gaboury L, Beaulieu R, et al. SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 2006;312:3701-3710
62. Oda T, Tian T, Inoue M, et al. Tumourigenic role of orphan nuclear receptor NR0B1 in lung adenocarcinoma. Am J Pathol 2009;175:1235-1245
63. Arvand A, Denny CT. Biology of EWS/ETS fusions in Ewing's family tumours. Oncogene 2001;20:5747-5754
64. Mendiola M, Carrillo J, García E, et al. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumours. Int J Cancer 2006;118:1381-1389
65. García-Aragoncillo E, Carrillo J, Lalli E, et al. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell cycle progression in Ewing tumour cells. Oncogene 2008;27:6034-6043
66. Gangwal K, Sankar S, Hollenhorst PC, et al. Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci USA 2008;105:10149-10154
67. Kinsey M, Smith R, Lessnick SL. NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Mol Cancer Res 2006;4:851-859
68. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007;1:39-49
69. Lepourcelet M, Chen YN, France DS, et al. Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 2004;5:91-102
70. Zhou J, Oakley RH, Cidlowski JA. DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X-chromosome, gene 1) selectively inhibits transactivation but not transrepression mediated by the glucocorticoid receptor in a LXXLL-dependent manner. Mol Endocrinol 2008;22:1521-1534
71. Holter E, Kotaja N, Mäkela S, et al. Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1. Mol Endocrinol 2002;16:515-528
72. Agoulnik IU, Krause WC, Bingman WE III, et al. Repressors of androgen and progesterone receptor action. J Biol Chem 2003;278:31136-31148
73. Song KH, Park YY, Park KC, et al. The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation. Mol Endocrinol 2004;18:1929-1940
74. Lopez D, Shea-Eaton W, Sanchez MD, et al. DAX-1 represses the high-density lipoprotein receptor through interaction with positive regulators sterol regulatory element-binding protein-1a and steroidogenic factor-1. Endocrinology 2001;142:5097-5106
75. Iyer AK, Zhang YH, McCabe ER. Dosage-sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome, gene 1 (DAX1) (NR0B1) and small heterodimer partner (SHP) (NR0B2) form homodimers individually, as well as DAX1-SHP heterodimers. Mol Endocrinol 2006;20:2326-2342
76. Park YY, Ahn SW, Kim HJ, et al. An autoregulatory loop controlling orphan nuclear receptor DAX-1 gene expression by orphan nuclear receptor ERRgamma. Nucleic Acids Res 2005;33:6756-6768
77. Kim GS, Lee GY, Nedumaran B, et al. The orphan nuclear receptor DAX-1 acts as a novel transcriptional corepressor of PPARgamma. Biochem Biophys Res Commun 2008;370:264-268
78. Nedumaran B, Hong S, Xie YB, et al. DAX-1 acts as a novel corepressor of orphan nuclear receptor HNF4alpha and negatively regulates the gluconeogenic enzyme gene expression. J Biol Chem 2009;284:27511-27523
79. Altincicek B, Tenbaum SP, Dressel U, et al. Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita. J Biol Chem 2000;275:7662-7667
80. Sugawara T, Abe S, Sakuragi N, et al. RIP 140 modulates transcription of the steroidogenic acute regulatory protein gene through interactions with both SF-1 and DAX-1. Endocrinology 2001;142:3570-3577
81. Crawford PA, Dorn C, Sadovsky Y, et al. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol Cell Biol 1998;18:2949-2956
82. Tamai KT, Monaco L, Alastalo TP, et al. Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol Endocrinol 1996;10:1561-1569